Locations:
Search IconSearch
March 25, 2021/Neurosciences/Spine Care

Ventral and Dorsal Surgical Approaches Perform Equally Well in Study of Cervical Spondylotic Myelopathy

No differences in patient-reported physical functioning at one year

imaging study showing cervical spondylotic myelopathy in the neck

One year after surgery for cervical spondylotic myelopathy, patients report similar improvement in physical and general health measures regardless of whether they underwent a ventral or dorsal surgical approach. That’s the primary finding of the multicenter randomized Cervical Spondylotic Myelopathy Surgical (CSM-S) trial, believed to be the first randomized study to compare alternative surgical approaches for this common condition. Results of the trial were published in the Journal of the American Medical Association (2021;325:942-951).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“Recent attention has focused on patient-reported quality of life for assessing surgical outcomes,” says the study’s senior author, Edward Benzel, MD, a neurosurgeon with Cleveland Clinic’s Center for Spine Health. “Ascertaining such information is especially important for cervical spondylotic myelopathy, given how often surgery is performed for this condition and the considerable practice variation in approaches.”

No consensus on optimal surgical approach to CSM

Cervical spondylotic myelopathy, the most common cause of spinal cord dysfunction, is frequently treated surgically in severe or progressive cases to decompress the spinal cord. In the U.S., ventral and dorsal decompression/fusion are the most common surgical interventions, but operations result in unsatisfactory outcomes in 30% of patients and frequently entail complications.

Evidence to date has failed to consistently show either the ventral or dorsal surgical approach to be superior to the other. The CSM-S trial was undertaken to compare the two strategies in terms of patient-reported physical functioning at one year.

Study design at a glance

The trial included patients with multilevel cervical spondylotic myelopathy from 14 large hospitals in the U.S. and one in Canada from April 2014 to March 2018. Patients were followed for up to two years.

The study’s 163 patients (mean age, 62 years; 49% women) were randomized to either ventral surgery (n = 63) or dorsal surgery (n = 100). Ventral surgery consisted of anterior cervical disk removal with instrumented fusion. Dorsal surgery consisted of either laminectomy with instrumented fusion or open-door laminoplasty, with the choice left to the surgeon’s discretion. Because of this variability in dorsal approaches, randomization followed a 2:3 scheme with more patients assigned to dorsal surgery.

Advertisement

One-year follow-up was conducted in 95% of study participants, and 80% completed two-year follow-up.

Results reveal few differences

The primary outcome was one-year change in the physical component summary score of the Short Form 36 Survey (SF-36 PCS), which assesses patient-reported physical functioning, limitations in work and activities due to pain, and physical and general health. Scores range from 0 to 100, with a change of 5 points or more considered clinically meaningful.

Mean improvements in one-year SF-36 PCS scores were not significantly different between the ventral surgery cohort (5.9 points) and the dorsal surgery group (6.2 points) (P = 0.86).

When the cohorts were compared across seven prespecified secondary outcomes, there were no significant differences between the groups on six of the outcomes — specifically, the modified Japanese Orthopaedic Association scale score, the Neck Disability Index, the EuroQol 5 Dimensions score, sagittal vertical axis, work status and heath resource utilization. The one exception was risk of any complications, which was significantly higher in the ventral surgery group than in the dorsal surgery group (48% vs. 24%; P = 0.002), driven largely by an excess of dysphagia with ventral surgery. There was no significant difference in incidence of major complications.

Key study takeaways

Dr. Benzel emphasizes two major points from this trial:

  • Ventral and dorsal surgeries result in similar improvements in patient-reported functioning. Both approaches were associated with meaningful clinical improvement at one and two years.
  • Surgery is effective for treating myelopathy, but complications are common. However, most complications were minor, including dysphagia, which resolved within the first postoperative year.

Advertisement

Laminectomy vs. laminoplasty: an unanswered question

The authors note that laminoplasty is preferred over ventral or dorsal fusion more often in Asia and Europe than in North America. Because of the small number of centers using laminoplasty in this study (five) and the nonrandomized protocol within the dorsal approach group, laminoplasty could not be adequately compared with the fusion procedures.

However, in nonrandomized analysis by treatment type, laminoplasty was associated with significantly better patient-reported functioning, fewer complications and less health resource utilization. The authors also note that reimbursement for laminoplasty is lower than for fusion in the U.S.

“Our findings on laminoplasty should be interpreted with caution,” Dr. Benzel concludes. “A more extensive evaluation — encompassing clinical and economic considerations — is needed to compare these three alternative surgical approaches. At the same time, the results associated with laminoplasty are very promising.”

Advertisement

Related Articles

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular

Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy

MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular

Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Ad